Status:
COMPLETED
A Modified Calculation Formula for Meibomian Gland Grading
Lead Sponsor:
Zhongnan Hospital
Conditions:
Meibomian Gland Dysfunction
Eligibility:
All Genders
18-80 years
Brief Summary
The meibomian gland (MG) is a modified sebaceous gland located in the upper and lower eyelids. The grades of MG loss (i.e. meiboscore) is calculated as the ratio between the area of the MGs and the ey...
Eligibility Criteria
Inclusion
- people aged 18 to 80
Exclusion
- Exclusion criteria included contact lens wearer, history of eye surgeries, systemic health conditions affecting ocular health and those who were unable to cooperate with examinations.
Key Trial Info
Start Date :
April 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 30 2023
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06106737
Start Date
April 1 2023
End Date
May 30 2023
Last Update
December 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zhongnan Hospital of Wuhan University
Wuhan, Hubei, China, 430071